论文部分内容阅读
三家医院5年来用尿激酶(UK)治疗急性心肌梗塞(AMI)118例。按给予剂量的大、中、小分为A、B、C 三组,冠状动脉再通率在给药7小时内分别为77.8、53、16.6%。3小时内B 组提高到75%,较A 组(78.9%)相比无显著差异(p>0.05),而出血、心律失常并发症明显减少。
Five hospitals treated 118 patients with acute myocardial infarction (AMI) with urokinase (UK) over the past five years. According to the dose given large, medium and small sub-divided into A, B, C three groups, coronary recanalization rate within 7 hours of administration were 77.8,53,16.6%. B group increased to 75% within 3 hours, no significant difference (P> 0.05) compared with A group (78.9%), while bleeding and arrhythmia complications were significantly reduced.